Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07080788 · ClinicalTrials.gov registry record · NA
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
A NA study of Pain and Smoking (Tobacco) Addiction, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07080788: Recruiting NA study of Pain and Smoking (Tobacco) Addiction, sponsored by University of Oklahoma.
NCT07080788 is a NA study of Pain and Smoking (Tobacco) Addiction that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 150 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07080788, a NA study of Pain and Smoking (Tobacco) Addiction, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to assess whether 4-weeks of verified smoking abstinence following financial incentive treatment for smoking cessation improves physiological markers of chronic pain risk in adult Native American smokers. The main aims to answer are: 1. Determine study feasibility. 2. Obtain effect sizes for changes in pain amplification and pain inhibition in abstinent vs non-abstinent Native Americans. 3. Obtain effect sizes for variables in the conceptual model of the Native American smoking-pain relationship.
Primary Outcome
Pain inhibition will be assessed using a conditioned pain modulation task with cold water as the conditioning stimulus and electric stimulations as the test stimulus.
Conditions Studied
Interventions
- BEHAVIORAL Smoking Cessation
Study Locations (1)
Oklahoma
- University of Oklahoma - Schusterman Center - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT07080788 shows while recruiting
NCT07080788 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (51% lower).
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Smoking Cessation is the first listed.
NCT07080788 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT07080788 about?
NCT07080788 is a clinical study titled "Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain". The goal of this pilot study is to assess whether 4-weeks of verified smoking abstinence following financial incentive treatment for smoking cessation improves physiological markers of chronic pain risk in adult Native American smokers. The main aims to answer are: 1. Determine study feasibility. ...
What is the current status of trial NCT07080788?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-09-01. Estimated completion is 2028-06.
What conditions does trial NCT07080788 study?
This clinical trial studies the following conditions: Pain, Smoking (Tobacco) Addiction, Smoking Cessation Intervention.
What interventions are being tested in trial NCT07080788?
The interventions under investigation include: Smoking Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT07080788?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07080788 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07080788's enrollment target sits among peer trials
150 114th of 374 higher than 255 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI